臨牀消化器内科 Vol.16 No.10(4-1)


特集名 重症潰瘍性大腸炎に対する最新の戦略
題名 重症潰瘍性大腸炎の治療戦略 (1) 副腎皮質ステロイド剤の使い方
発刊年月 2001年 09月
著者 棟方 昭博 弘前大学医学部第一内科
著者 石黒 陽 弘前大学医学部第一内科
【 要旨 】 重症潰瘍性大腸炎に対する副腎皮質ステロイド剤の果たす役割は大きいが,その投与方法いかんによっては予後不良を招くことになるので細心の注意を払いながら行う.具体的には,診断と病態の把握,投与開始のタイミングおよび投与期間,効果判定の時期が大切で,反応性の有無によっては時期を逸することなく,他の治療法への変更を速やかに行う.治療の原則は,重症例に関しては入院のうえ,脱水,電解質異常,貧血,低蛋白血症,栄養障害などに対する対策が必要である.
Theme The Newest Strategies for Severe Ulcerative Colitis
Title Steroid Therapies for Severe Ulcerative Colitis
Author Akihiro Munakata First Department of Internal Medicine, Hirosaki University School of Medicine
Author Yoh Ishiguro First Department of Internal Medicine, Hirosaki University School of Medicine
[ Summary ] With advances in steroid therapies, death from ulcerative colitis (UC) is now rare but morbidity has increased due to delays, in surgical therapy. In the medical management of severe UC we are occasionally presented with severe symptoms, including minor perforations, toxic megacolon and massive bleeding. Treatment in these cases is as follows: 1-1.5mg/kg of steroid is administered. Patients with severe colitis should not receive fluids or food. Intensive monitoring with daily abdominal radiographs, determination of complete blood counts and serum electrolytes should be performed. Support with fluid and electrolytes, blood transfusions, and human albumin should be administered also. Antibiotics should be added to the regimen. Any deterioration or failure to improve within a few days is an indication for colectomy, or other therapies.
戻る